🇺🇸 FDA
Patent

US 8916556

Pharmaceutical formulations comprising neurotrophin mimetics

granted A61KA61K31/155A61K31/445

Quick answer

US patent 8916556 (Pharmaceutical formulations comprising neurotrophin mimetics) held by The United States of America represented by the Department of Vetran Affairs expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America represented by the Department of Vetran Affairs
Grant date
Tue Dec 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/155, A61K31/445, A61K31/496, A61K31/497